Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic

This cross-sectional study compares trends in prescribing buprenorphine to all Medicaid beneficiaries before and after the start of the COVID-19 pandemic.

Detalles Bibliográficos
Autores principales: Dowd, William N., Mark, Tami L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948527/
https://www.ncbi.nlm.nih.gov/pubmed/35323952
http://dx.doi.org/10.1001/jamanetworkopen.2022.4058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948527/
https://www.ncbi.nlm.nih.gov/pubmed/35323952
http://dx.doi.org/10.1001/jamanetworkopen.2022.4058

Ejemplares similares